Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 6/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ENPP1 | P22413 | 3/20 | 0.52 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29529385 | 1.00 | TYMP (0.63) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL29574745 | 1.00 | TYMP (0.63) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL1774839 | 1.00 | TYMP (0.63) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL1774838 | 1.00 | TYMP (0.63) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL7065756 | 0.93 | TYMP (0.71) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL7065752 | 0.93 | TYMP (0.71) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL18817976 | 0.93 | TYMP (0.58) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL18486220 | 0.90 | TYMP (0.62) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL4820943 | 0.89 | TYMP (0.50) | TYMPADORA1POLBENPP1P2RY1 | |
| SCHEMBL22216348 | 0.88 | PNP (0.59) | TYMPADORA1NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6329346-B1 | POLYNUCLEOTIDES WITH CARRIERS | ROCHE DIAGNOSTICS GMBH (DE) | 2001-12-11 | — | — | US | disclosed |
| EP-0611373-B1 | OLIGO-2'-DEOXYNUCLEOTIDES AND THEIR USE AS DRUGS WITH AN ANTIVIRAL ACTION | BOEHRINGER MANNHEIM GMBH (DE) | 1997-03-26 | — | — | EP | disclosed |